OLMA OLEMA PHARMACEUTICALS INC
2026Q1 · CUSIP 68062P106 · Sector: Healthcare & Biotech
Danger · Dual-confirm: breadth + price
Holders
195
Δ holders QoQ
-5
Breadth percentile
Top 78%
Whale holders
106
Δ whales
+9
Inst. holding value
$1.5B
New positions
46
Closed positions
51
Price momentum (1Q)
-43.0%
Put / Call
8/17
Breadth history (34 quarters)
Past Lit Events & Aftermath 4 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q4 | Top 6% | -43.0% | — |
| 2024Q4 | Top 19% | -4.8% | +7.7% |
| 2023Q3 | Top 18% | -14.5% | -43.3% |
| 2023Q2 | Top 10% | +66.8% | +55.6% |
Options Sentiment
Put holders
8
QoQ: +3
Call holders
17
QoQ: +9
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-2.03
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Net margin
—
ROE
-38.5%
Debt ratio
9.4%
FCF (TTM)
—
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.